SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(6.0%),Invus Public Equities Advisors, LLC(6.0%), etc.
SILENCE THERAPEUTICS PLC | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Ian Griffiths(16.9%),Ora Capital Limited(7.8%)
SILENCE THERAPEUTICS PLC | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lombard Odier Asset Management (USA) Corp(10.4%)
SILENCE THERAPEUTICS PLC | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(5.43%),Deep Track Biotechnology Master Fund, Ltd.(5.43%), etc.
SILENCE THERAPEUTICS PLC | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(2.2 %),GOLDMAN SACHS & CO. LLC(2.2 %)
SILENCE THERAPEUTICS PLC | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(7.8%),Invus Public Equities Advisors, LLC(7.8%), etc.
SILENCE THERAPEUTICS PLC | SC 13G: Statement of acquisition of beneficial ownership by individuals-Invus Public Equities, L.P.(6.8%),Invus Public Equities Advisors, LLC(6.8%), etc.
SILENCE THERAPEUTICS PLC | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Ian Griffiths(26.58%)
SILENCE THERAPEUTICS PLC | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TCG Crossover GP I, LLC(5.9%),TCG Crossover Fund I, L.P.(5.9%), etc.
SILENCE THERAPEUTICS PLC | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lombard Odier Asset Management (USA) Corp(10.8%)
SILENCE THERAPEUTICS PLC | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(5.1 %),GOLDMAN SACHS & CO. LLC(5.1 %)
SILENCE THERAPEUTICS PLC | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Ian Griffiths(25.42%)
SILENCE THERAPEUTICS PLC | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(5.44%),Deep Track Biotechnology Master Fund, Ltd.(5.44%), etc.
SILENCE THERAPEUTICS PLC | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover Management, LLC(5.9%)
SILENCE THERAPEUTICS PLC | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Ian Griffiths(28.4%)
SILENCE THERAPEUTICS PLC | SC 13D: Statement of acquisition of beneficial ownership by individuals-Richard Ian Griffiths(27.0%)
SILENCE THERAPEUTICS PLC | SC 13G: Statement of acquisition of beneficial ownership by individuals-Robert Quested(7.81%)
SILENCE THERAPEUTICS PLC | SC 13G: Statement of acquisition of beneficial ownership by individuals-Richard Ian Griffiths(23.05%)
SILENCE THERAPEUTICS PLC | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lombard Odier Asset Management (USA) Corp(11.6%)
SILENCE THERAPEUTICS PLC | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mallinckrodt plc(5.64%),Cache Holdings Limited(5.64%)
No Data
No Data